Press release
Levetiracetam Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)
Levetiracetam market is anticipated to grow at a significant CAGR during the forecast period (2023-2029). Levetiracetam is a medication that is sold under the brand name Keppra among others and is used to treat epilepsy. This medicine is used for partial-onset, myoclonic, or tonic-clonic seizures. It is consumed by mouth as an immediate or extended-release formulation or by injecting directly into a vein. The major factor for the growth of the market is the rising prevalence of epilepsy.According to the World Health Organization (WHO), in 2019, epilepsy is one of the most common neurological diseases globally with around 50 million people diagnosed with it. Additionally, almost 80% of people with epilepsy live in low and middle-income countries and up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated. However, the risk of mortality is three times higher in people with epilepsy than in the general populace. Hence the rising prevalence of epilepsy is driving the demand for levetiracetam which in turn is boosting the market growth.
Some major key players in the market include Mylan NV, UCB Pharma Ltd., and Novartis International AG (Sandoz Inc.), among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2018, Sandoz Canada announced the launch of Sandoz Levetiracetam 1000 mg to be used as adjunctive therapy to manage patients with epilepsy who are not satisfactorily controlled by conventional therapy.
To Request a Sample of our Report on Levetiracetam Market: https://www.omrglobal.com/request-sample/levetiracetam-market
Market Coverage
The market number available for - 2022-2029
Base year- 2022
Forecast period- 2023-2029
Segment Covered-
By Form
By Application
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- Mylan NV, UCB Pharma Ltd., and Novartis International AG (Sandoz Inc.), among others.
Levetiracetam Market Report by Segment
By Form
Tablet
Syrup
Injection
By Application
Myoclonic Treatment
Tonic-clonic Seizures Treatment
A full Report of Levetiracetam Market is Available at: https://www.omrglobal.com/industry-reports/levetiracetam-market
Levetiracetam Market Report by Region
North America
United States
Canada
Europe
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific
India
China
Japan
South Korea
Rest of APAC
Rest of the World
Latin America
Middle East & Africa
Reasons to buy from us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
https://www.asiatimeskorea.com/news/2029%eb%85%84%ea%b9%8c%ec%a7%80-%ea%b2%ac%ec%8b%a4%ed%95%9c-%ed%99%95%ec%9e%a5%ec%9d%84-%eb%aa%a9%ea%b2%a9%ed%95%98%eb%8a%94-%eb%8d%95%ed%8a%b8%eb%a6%ac%ec%8a%a4-%eb%82%9c%eb%b0%a9-%eb%b0%8f/363339/
https://monblogapple.com/2023/02/27/le-marche-des-trois-roues-electriques-generera-des-revenus-record-dici-2029/
https://www.diario-ya.com/regionales/%e5%88%b0-2029-%e5%b9%b4%ef%bc%8c%e9%a3%9f%e5%93%81%e6%8a%97%e6%b0%a7%e5%8c%96%e5%8a%91%e5%b8%82%e5%a0%b4%e5%b0%87%e5%87%ba%e7%8f%be%e9%a9%9a%e4%ba%ba%e7%9a%84%e5%a2%9e%e9%95%b7/453258/
https://revistaeconomiasocial.com/2023/02/27/el-mercado-de-medicamentos-para-el-sindrome-del-intestino-irritable-con-estrenimiento-sii-c-generara-ingresos-record-para-2029/
https://sportmsr.com/%d8%b3%d9%88%d9%82-%d9%86%d8%b8%d8%a7%d9%85-%d8%a7%d9%84%d9%81%d8%b1%d8%b2-%d9%81%d9%8a-%d8%ac%d9%85%d9%8a%d8%b9-%d8%a3%d9%86%d8%ad%d8%a7%d8%a1-%d8%a7%d9%84%d8%b9%d8%a7%d9%84%d9%85-%d8%aa%d8%ad/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Levetiracetam Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029) here
News-ID: 2953696 • Views: …
More Releases from Orion Market Research

GMP Testing Service Market Size Future Scope, Demands and Projected Industry Gro …
The GMP Testing Service Market was valued at approximately USD 2.5 billion in 2024 and is projected to reach around USD 5.8 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2033.
GMP Testing Service Market Overview:
The GMP Testing Service Market is experiencing robust growth driven by increasing regulatory requirements and the need for quality assurance in pharmaceutical and biotechnology industries. Good Manufacturing Practice…

Patient Registry Software Market Size Analysis, Competitive Insights, Leading Pl …
The Patient Registry Software Market was valued at approximately USD 700 million in 2024 and is anticipated to reach around USD 1.8 billion by 2033, growing at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2033.
Patient Registry Software Market Overview:
The Patient Registry Software Market is expanding rapidly as healthcare providers increasingly adopt digital solutions to collect, manage, and analyze patient data for improved clinical outcomes. These software…

Automotive Film Market Analysis Current Landscape and Future Outlook
The Automotive Film Market was valued at approximately USD 2.1 billion in 2024 and is projected to reach around USD 4.3 billion by 2033, growing at a compound annual growth rate (CAGR) of 8.2% from 2025 to 2033.
Automotive film Market Overview:
The Automotive Film Market is growing steadily as consumers and manufacturers increasingly prioritize vehicle aesthetics, UV protection, and heat insulation. These films are widely used for window tinting, paint…

Cold Chain Monitoring Market Size Unlocking New Opportunities for Success
The Cold Chain Monitoring Market was valued at approximately USD 3.8 billion in 2024 and is expected to reach around USD 9.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 11.4% from 2025 to 2033.
Cold Chain Monitoring Market Overview:
The Cold Chain Monitoring Market is witnessing significant growth driven by the increasing need to maintain product integrity across pharmaceutical, food, and chemical industries. Effective monitoring solutions help…
More Releases for Levetiracetam
Levetiracetam Market Report- Growth with Top Key Vendors like- UCB Pharma, Glaxo …
The research report provides region-wise and country-wise analyses of the Levetiracetam Market. Additionally, Levetiracetam Market provides insights about main regions like Asia-Pacific, Europe, North America, South America, Latin, Middle East, and Africa. Moreover, Levetiracetam Market research report offers in-depth information about lucrative emerging markets and analyzes penetration across the significant market segments.
Get FREE PDF Sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5394514
Levetiracetam market is segmented by Type and by Application. Players, stakeholders,…
Levetiracetam Market Size, Industry Trends, Share and Forecast 2021-2027
The global levetiracetam market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Levetiracetam is a medication that is sold under the brand name Keppra among others and is used to treat epilepsy. This medicine is used for partial-onset, myoclonic, or tonic-clonic seizures. It is consumed by mouth as an immediate or extended-release formulation or by injecting directly into a vein. The major factor for the…
Levetiracetam Market Growth 2021 | Market Trends, Covid-19 Impact, Business Outl …
A number of significant businesses in the market are found in the Levetiracetam Market study. It helps readers comprehend the strategies and partnerships of competitors on the market. A great microscopic survey of the levetiracetam market is provided in the paper.
In the ""Levetiracetam Market"" prediction period, readers are able to determine the footprints of manufacturers in terms of their world market sales, manufacturers' global prices, and manufacturers' sales. This research…
Global Levetiracetam Market - ABA Chem, Afton, SVK Laboratories Private Limited, …
According to a comprehensive study by KD Market Insights analyzes and forecasts the Levetiracetam Market at both global and regional level. The report provides an analysis of 6 years, in which 2017 is the base year, 2018 as an estimated year and 2019-2023 is forecasted period. The report consists of overall market size in 2017 and its anticipated growth in further 6 years. It gives grasp about the high demanding…
Epilepsy Drugs Market Insights, Global Analysis and Future Forecast to 2025
ReportsnReports.com adds "Epilepsy Drugs Market by Country (US, UK, France, etc), Drugs (Vimpat, Keppra, Sabril, Onfi, etc), Treatment Drugs Generation (First, Second, Third), Companies & Forecast" report to its research store.
Access this Epilepsy Drugs Market report at https://www.reportsnreports.com/reports/1899648-epilepsy-drugs-market-by-country-us-uk-france-etc-drugs-vimpat-keppra-sabril-onfi-etc-treatment-drugs-generation-first-second-third-companies-forecast.html.
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types -…
Epilepsy Drugs Market Growth and Analysis by Key Players 2018: Vimpat(Lacosamide …
A report added to the rich database of Qurate Business Intelligence, titled “Global Epilepsy Drugs Market Size, Status and Forecast 2023”, provides a 360-degree overview of the worldwide market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the data reliable in context…